Menu

THE JORDANIAN PHARMACEUTICAL MANUFACTURING Financial

Trading Information

2019 2018 2017
Par Value/Share (JD) 1.00 1.00 1.00
Closing Price (JD) 0.27 0.49 0.44
Value Traded (JD) 225,687 583,845 456,537
No. of Shares Traded 632,989 1,527,080 954,311
No. of Transactions 656 1,520 1,260
No. of Subscribed Shares 25,312,500 25,312,500 25,312,500
Market Capitalization (JD) 6,834,375 12,403,125 11,137,500
Fiscal Year Ended 31/12/2019 31/12/2018 31/12/2017

Assets (JD)

2019 2018 2017
Cash on Hand & at Banks 450,693 238,473 1,189,558
Notes Receivable 0 0 0
Post Dated Cheques 743,295 703,790 1,105,443
Short Term Investments 0 0 0
Inventory 5,773,312 5,040,464 7,540,524
Spare Parts 0 0 0
Total Current Assets 21,763,400 27,428,765 26,252,775
Long Term Investments 3,152,726 4,093,265 13,467,440
Fixed Assets, Net 3,304,350 3,316,875 3,244,878
Lands 490,127 490,127 490,127
Projects in Progress 0 0 0
Total Fixed Assets 3,794,477 3,807,002 3,735,005
Other Assets 9,974,851 10,240,839 2,255,599
Total Assets 38,685,454 45,569,871 45,710,819

Liabilities (JD)

2019 2018 2017
Credit Banks 949,830 707,156 673,281
Short Term Loans 1,968,475 7,261,346 0
Accrued Part of Long Term Loans 0 0 0
Total Current Liabilities 15,308,346 20,079,503 16,782,606
Long Term Loans & Notes Payable 11,954,500 5,067,524 5,266,062
Corporate Bonds 0 0 0
Other Liabilities 9,820,667 11,481,991 10,104,084
Total Liabilities 37,083,513 36,629,018 32,152,752

Shareholders Equity (JD)

2019 2018 2017
Authorized Capital 25,312,500 25,312,500 25,312,500
Subscribed Capital 25,312,500 25,312,500 25,312,500
Paid in Capital 25,312,500 25,312,500 25,312,500
Compulsory Reserves 2,059,193 2,059,193 2,027,703
Voluntary Reserve 0 0 0
Other Reserves 0 0 0
Issuance Premium 0 0 0
Issuance Discount 0 0 0
Treasury Stocks 0 0 0
Cash Dividends 0 0 0
Stock Dividends 0 0 0
Accumulated Change in Fair Value -2,354,705 -930,000 436,720
Retained Earnings -23,596,782 -17,737,444 -14,140,002
Total Shareholders Equity 1,420,206 8,704,249 13,636,921
Non-controlling Interest 181,735 236,604 -78,854
Total Liabilities & Shareholders Equity 38,685,454 45,569,871 45,710,819

Income Statement (JD)

2019 2018 2017
Operating Revenues 9,977,197 22,205,163 27,488,192
Operating Expenses 7,076,480 12,445,255 9,750,369
Gross Profit 2,900,717 9,759,908 17,737,823
General and Administrative Expenses 2,320,621 2,527,565 2,210,788
Selling and Distribution Expenses 5,285,945 5,434,794 9,349,495
Depreciation (Period) 740,631 643,028 1,672,349
Other Operating Expenses 1,918,111 4,100,900 639,421
Net Operating Income -6,623,960 -2,303,351 5,538,119
Other Revenues 2,033,120 135,305 4,156,356
Other Expenses 169,061 93,956 6,565,018
Income Before Interest & Tax -4,759,901 -2,262,002 3,129,457
Interest Expenses 1,147,462 1,800,182 1,357,028
Net Income Before Tax -5,907,363 -4,062,184 1,772,429
Income Tax (Period) 6,563 51,293 123,148
Income Tax (Previous Years) 0 0 735,783
Universities and Research Train Fees 0 0 0
Board of Directors Remuniration 0 0 45,000
Net Income -5,913,926 -4,113,477 868,498
Non-controlling Interest -54,588 -17,437 -152,122
Net Income Pertains to Shareholders -5,859,338 -4,096,040 1,020,620

Cash Flow (JD)

2019 2018 2017
Cash Balance (Beginning) -468,683 516,277 207,704
Net Cash Flow from (Used in) Operating Activities -1,591,202 -1,863,269 1,643,291
Net Cash Flow from (Used in) Investing Activities -17,386 -565,111 -589,618
Net Cash Flow from (Used in) Financing Activities 1,578,134 1,443,420 -71,819
Cash Balance (Ending) -499,137 -468,683 1,189,558

Financial Ratios

2019 2018 2017
Turnover Ratio % 2.501 6.033 3.770
Earning Per Share (JD) -0.232 -0.162 0.040
Dividend Per Share (JD) 0.000 0.000 0.000
Book Value Per Share (JD) 0.056 0.344 0.539
Price Earnings Ratio (Times) -1.166 -3.028 10.913
Dividend Yield % 0.000 0.000 0.000
Dividend Per Share to Earning Per Share % 0.000 0.000 0.000
Price to Book Value (Times) 4.812 1.425 0.817
Gross Margin % 29.074 43.953 64.529
Margin Before Interest and Tax % -47.708 -10.187 11.385
Profit Margin % -59.274 -18.525 3.160
Return On Assets % -15.287 -9.027 1.900
Return On Equity % -412.570 -47.058 7.484
Debt Ratio % 95.859 80.380 70.340
Equity Ratio % 4.141 19.620 29.661
Interest Coverage Ratio (Times) -4.148 -1.257 2.306
Total Assets Turnover (Times) 0.258 0.487 0.601
Fixed Assets Turnover (Times) 2.629 5.833 7.360
Working Capital Turnover (Times) 1.546 3.021 2.903
Current Ratio (Times) 1.422 1.366 1.564
Working Capital (JD) 6,455,054.000 7,349,262.000 9,470,169.000